We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





Medlab Middle East 2025 Opens with Groundbreaking Innovations

By LabMedica International staff writers
Posted on 03 Feb 2025

The 24th edition of Medlab Middle East, the MENA region’s largest medical laboratory exhibition and congress, is being held at Dubai World Trade Centre from 3-6 February. More...

Organized by Informa Markets (London, UK), the event themed ‘Empowering today’s medical labs for tomorrow’s future’ features over 800 exhibitors from 40 countries, with 20,000 visitors exploring the latest technology and updates for the laboratory industry. Medlab Middle East showcases the latest innovations and technologies across eight dynamic product categories, which include disposables and consumer goods, emergency medicine, imaging and diagnostics, healthcare and general services, IT, laboratory, medical equipment and devices, and pharma and nutrition.

The 24th edition builds on the success of Medlab Middle East 2024 when the event generated an estimated business value of USD 670 million, fueling medical laboratory growth across the Middle East and beyond. The event features the most prominent names in the industry, with key exhibitors showcasing their innovations including Snibe, PureLab, World Data Exchange, Merck and Abbott. The world’s only multidisciplinary congress in the medical laboratory industry, the Medlab Middle East Congress returns with 12 CME-accredited conferences in Lab Management, Clinical Chemistry, Lab Quality, Hematology, Clinical Microbiology, Molecular Diagnostics, Blood Transfusion Medicine and Cellular Therapy, Histopathology, Lab Sustainability and Immunology. A new Lab Automation conference debuts this year, designed to explore the transformative impact of automation and IT workflows on laboratory operations.

The Congress features 150 local and international speakers and 60 VIP guests and is expected to draw over 4,000 delegates from the medical and laboratory fields. Key topics explored at the event include ‘The role of laboratory leadership to prepare laboratories for outbreak detection’, ‘Advances in stem cell therapy’ and ‘The past and the future for biomedical sciences and career options for the next generation’. Medlab Middle East 2025 is introducing two new leadership forums dedicated to women’s health and precision medicine. The Women’s Health Leadership Forum, held on the opening day of Medlab Middle East, aims to enhance women’s health through laboratory diagnostics. The event showcases cutting-edge innovations, addresses key challenges and uncovers collaboration opportunities that will enhance diagnostic capabilities for addressing women’s health needs.

The Precision Medicine Leadership Forum, featuring precision medicine experts, aims to offer insights from top experts in precision medicine, fostering a dialogue around cutting-edge innovations in genetics, personalized healthcare and new targeted therapies shaping the future of patient care. The program includes sessions on how genetic data is being integrated into treatment plans and the impact of precision medicine on improving patient care, among several other key topics in the precision medicine field. Also new for the 2025 edition, the Global Lab Leaders Breakfast Forum unites Medlab portfolio global advisers, scientific chairs, international partners and stakeholders in an exclusive, invitation-only dialogue, concentrating on topics that are crucial to advancing laboratory practices worldwide. The GCC Lab Leaders Breakfast Forum will see a gathering of officials, experts, and specialists from both public and private sector laboratories, as well as national standardization bodies across the GCC region. The event aims to foster collaboration and open dialogue on critical topics, including laboratory management, quality assurance, and proficiency testing. The ABCHealth Session at Medlab Middle East explores the transformative role of AI and advanced technologies in reshaping diagnostic business models across Africa.

“The 2025 edition of Medlab Middle East promises to be a landmark event which spotlights cutting-edge advancements and sustainable practices in laboratory medicine,” said Tom Coleman, Group Exhibition Director, Informa Markets Healthcare. “The event offers a unique opportunity to connect with a diverse range of companies and professionals in the medical laboratory industry, opening doors to new networks and opportunities for growth.”


Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
HbA1c Test
HbA1c Rapid Test
New
Unstirred Waterbath
HumAqua 5
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.